Home
|
Search
|
Glossary
|
Contact Us
Overview
Leadership Team
Senior Executive Officers
Board of Directors
Ethics Advisory Board
Careers
Contact Us
Our Technology
Regenerative Medicine
Research Programs
Blastomere Program
Cellular Reprogramming
Stem Cell Differentiation
Intellectual Property
Overview
Potential Markets
Myoblast Program
RPE Program
HG Program
Fact Sheet
Press Releases
Recent News
Conference Presentations
Scientific Papers
Media Gallery
Media Contact
Overview
SEC Filings
Insider Filings
Research Reports
Corporate Governance
Committee Charters
Whistleblower Hotline
Overview
SEC Filings
Insider Filings
Research Reports
Corporate Governance
Committee Charters
Whistleblower Hotline
Corporate Governance
03/29/2006 04:56 PM
Advanced Cell Technology Code Of Business Conduct And Ethics
OTCBB:ACTC.OB
Quote: $0.0998
Change: -0.0042
Date: 03/14/10
Time: 01:26:43 pm
Delay: 20 minutes